Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Isabel Pérez‐Martínez"'
Autor:
Ivan Guerra, Luis Bujanda, Miriam Mañosa, Isabel Pérez-Martínez, María José Casanova, Luisa de la Peña, Marina de Benito, Montserrat Rivero, Pilar Varela, Lorena Bernal, Ana Carolina Franco, Yolanda Ber, Marta Piqueras, Carlos Tardillo, Ángel Ponferrada, Sonsoles Olivares, Alfredo J. Lucendo, Pau Gilabert, Mónica Sierra Ausín, María Bellart, Amaia Herrarte, Margalida Calafat, Ruth de Francisco, Javier P. Gisbert, Jordi Guardiola, Eugeni Domènech, Fernando Bermejo
Publikováno v:
Cancers, Vol 15, Iss 3, p 750 (2023)
An increased risk of lymphoma has been described in patients with inflammatory bowel disease (IBD). The aims of our study were to determine the clinical presentation, the previous exposure to immunosuppressive and biologic therapies, and the evolutio
Externí odkaz:
https://doaj.org/article/d7733158a52b471c906061627750146a
Autor:
Alfredo J. Lucendo, Cecilio Santander, Edoardo Savarino, Danila Guagnozzi, Isabel Pérez-Martínez, Antonia Perelló, Antonio Guardiola-Arévalo, Jesús Barrio, María Elena Betoré-Glaria, Carolina Gutiérrez-Junquera, Constanza Ciriza de los Ríos, Francesca Racca, Sonia Fernández-Fernández, Leonardo Blas-Jhon, Anne Lund Krarup, Susana de la Riva, Juan E. Naves, Silvia Carrión, Juan Armando Rodríguez Oballe, Natalia García-Morales, Sonsoles Tamarit-Sebastián, Pilar Navarro, Ángel Arias, Emilio J. Laserna-Mendieta
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: The growing prevalence of eosinophilic esophagitis (EoE) represents a considerable burden to patients and health care systems. Optimizing cost-effective management and identifying mechanisms for disease onset and progression are required.
Externí odkaz:
https://doaj.org/article/43db2724b56b4a728452b2fac2d7ffa2
Autor:
Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, Isabel Vera, María Dolores Martín-Arranz, Iván Guerra, Javier P. Gisbert, Francisco Mesonero, Olga Benítez, Carlos Taxonera, Ángel Ponferrada-Díaz, Marta Piqueras, Alfredo J. Lucendo, Berta Caballol, Míriam Mañosa, Pilar Martínez-Montiel, Maia Bosca-Watts, Jordi Gordillo, Luis Bujanda, Noemí Manceñido, Teresa Martínez-Pérez, Alicia López, Cristina Rodríguez-Gutiérrez, Santiago García-López, Pablo Vega, Montserrat Rivero, Luigi Melcarne, María Calvo, Marisa Iborra, Manuel Barreiro de Acosta, Beatriz Sicilia, Jesús Barrio, José Lázaro Pérez Calle, David Busquets, Isabel Pérez-Martínez, Mercè Navarro-Llavat, Vicent Hernández, Federico Argüelles-Arias, Fernando Ramírez Esteso, Susana Meijide, Laura Ramos, Fernando Gomollón, Fernando Muñoz, Gerard Suris, Jone Ortiz de Zarate, José María Huguet, Jordina Llaó, Mariana Fe García-Sepulcre, Mónica Sierra, Miguel Durà, Sandra Estrecha, Ana Fuentes Coronel, Esther Hinojosa, Lorenzo Olivan, Eva Iglesias, Ana Gutiérrez, Pilar Varela, Núria Rull, Pau Gilabert, Alejandro Hernández-Camba, Alicia Brotons, Daniel Ginard, Eva Sesé, Daniel Carpio, Montserrat Aceituno, José Luis Cabriada, Yago González-Lama, Laura Jiménez, María Chaparro, Antonio López-San Román, Cristina Alba, Rocío Plaza-Santos, Raquel Mena, Sonsoles Tamarit-Sebastián, Elena Ricart, Margalida Calafat, Sonsoles Olivares, Pablo Navarro, Federico Bertoletti, Horacio Alonso-Galán, Ramón Pajares, Pablo Olcina, Pamela Manzano, Eugeni Domènech, Maria Esteve, on behalf of the ENEIDA Registry of GETECCU
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 24, p 7540 (2022)
(1) Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with inflammatory bowel disease (IBD). Therefore, the aim of this study was to assess these differences between infected and non
Externí odkaz:
https://doaj.org/article/7232d47531d742038b662bff5198ac94
Autor:
Sabino Riestra, Carlos Taxonera, Yamile Zabana, Daniel Carpio, María Chaparro, Jesús Barrio, Montserrat Rivero, Antonio López-Sanroman, María Esteve, Ruth de Francisco, Guillermo Bastida, Santiago García-López, Miriam Mañosa, María Dolores Martin-Arranz, José Lázaro Pérez-Calle, Jordi Guardiola, Fernando Muñoz, Laura Arranz, José Luis Cabriada, Mariana Fe García-Sepulcre, Mercè Navarro, Miguel Ángel Montoro-Huguet, Elena Ricart, Fernando Bermejo, Xavier Calvet, Marta Piqueras, Esther Garcia-Planella, Lucía Márquez, Miguel Mínguez, Manuel Van Domselar, Luis Bujanda, Xavier Aldeguer, Beatriz Sicilia, Eva Iglesias, Guillermo Alcaín, Isabel Pérez-Martínez, Valeria Rolle, Andrés Castaño-García, Javier P. Gisbert, Eugeni Domènech, on behalf of the ENEIDA registry from GETECCU
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 13, p 3915 (2022)
(1) Aims: Patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (TB), usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and treatment decreases the risk of TB. This study
Externí odkaz:
https://doaj.org/article/d42e2872dbab452290c46b2afed81491
Autor:
Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, Isabel Vera, María Dolores Martín-Arranz, Iván Guerra, Javier P. Gisbert, Francisco Mesonero, Olga Benítez, Carlos Taxonera, Ángel Ponferrada-Díaz, Marta Piqueras, Alfredo J. Lucendo, Berta Caballol, Míriam Mañosa, Pilar Martínez-Montiel, Maia Bosca-Watts, Jordi Gordillo, Luis Bujanda, Noemí Manceñido, Teresa Martínez-Pérez, Alicia López, Cristina Rodríguez-Gutiérrez, Santiago García-López, Pablo Vega, Montserrat Rivero, Luigi Melcarne, Maria Calvo, Marisa Iborra, Manuel Barreiro de-Acosta, Beatriz Sicilia, Jesús Barrio, José Lázaro Pérez, David Busquets, Isabel Pérez-Martínez, Mercè Navarro-Llavat, Vicent Hernández, Federico Argüelles-Arias, Fernando Ramírez Esteso, Susana Meijide, Laura Ramos, Fernando Gomollón, Fernando Muñoz, Gerard Suris, Jone Ortiz de Zarate, José María Huguet, Jordina Llaó, Mariana Fe García-Sepulcre, Mónica Sierra, Miguel Durà, Sandra Estrecha, Ana Fuentes Coronel, Esther Hinojosa, Lorenzo Olivan, Eva Iglesias, Ana Gutiérrez, Pilar Varela, Núria Rull, Pau Gilabert, Alejandro Hernández-Camba, Alicia Brotons, Daniel Ginard, Eva Sesé, Daniel Carpio, Montserrat Aceituno, José Luis Cabriada, Yago González-Lama, Laura Jiménez, María Chaparro, Antonio López-San Román, Cristina Alba, Rocío Plaza-Santos, Raquel Mena, Sonsoles Tamarit-Sebastián, Elena Ricart, Margalida Calafat, Sonsoles Olivares, Pablo Navarro, Federico Bertoletti, Horacio Alonso-Galán, Ramón Pajares, Pablo Olcina, Pamela Manzano, Eugeni Domènech, Maria Esteve, on behalf of the ENEIDA registry of GETECCU
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 2, p 421 (2022)
We aim to describe the incidence and source of contagion of COVID-19 in patients with IBD, as well as the risk factors for a severe course and long-term sequelae. This is a prospective observational study of IBD and COVID-19 included in the ENEIDA re
Externí odkaz:
https://doaj.org/article/ee1438208544486496eaab286af48373
Autor:
Sergio Raposeiras-Roubin, Emad Abu-Assi, Berenice Caneiro-Queija, Rafael Cobas-Paz, Lucía Rioboo-Lestón, Cristina García Rodríguez, Cruz Giraldez Lemos, María Blanco Vidal, Beatriz Ogando Guillán, Isabel Pérez Martínez, Emilio Paredes-Galán, Víctor Jimenez-Díaz, Jose Antonio Baz-Alonso, Francisco Calvo-Iglesias, Andrés Íñiguez-Romo
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 37, Iss 3, Pp 239-245 (2018)
Introduction: Beta-blocker doses that have been shown to be effective in randomized clinical trials are not commonly used in daily clinical practice. The aim of this study was to analyze whether there is a prognostic benefit of high rather than low d
Externí odkaz:
https://doaj.org/article/608fd55702eb413da76a085a6474889c
Autor:
María José García, Montserrat Rivero, José Miranda-Bautista, Iria Bastón-Rey, Francisco Mesonero, Eduardo Leo-Carnerero, Diego Casas-Deza, Carmen Cagigas Fernández, Albert Martin-Cardona, Ismael El Hajra, Nerea Hernández-Aretxabaleta, Isabel Pérez-Martínez, Esteban Fuentes-Valenzuela, Nuria Jiménez, Cristina Rubín de Célix, Ana Gutiérrez, Cristina Suárez Ferrer, José María Huguet, Agnes Fernández-Clotet, María González-Vivó, Blanca Del Val, Jesús Castro-Poceiro, Luigi Melcarne, Carmen Dueñas, Marta Izquierdo, David Monfort, Abdel Bouhmidi, Patricia Ramírez De la Piscina, Eva Romero, Gema Molina, Jaime Zorrilla, Cristina Calvino-Suárez, Eugenia Sánchez, Andrea Nuñez, Olivia Sierra, Beatriz Castro, Yamile Zabana, Irene González-Partida, Saioa De la Maza, Andrés Castaño, Rodrigo Nájera-Muñoz, Luis Sánchez-Guillén, Micaela Riat Castro, José Luis Rueda, José Manuel Benítez, Pedro Delgado-Guillena, Carlos Tardillo, Elena Peña, Santiago Frago-Larramona, María Carmen Rodríguez-Grau, Rocío Plaza, Pablo Pérez-Galindo, Jesús Martínez-Cadilla, Luis Menchén, Manuel Barreiro-De Acosta, Rubén Sánchez-Aldehuelo, María Dolores De la Cruz, Luis Javier Lamuela, Ignacio Marín, Laura Nieto-García, Antonio López-San Román, José Manuel Herrera, María Chaparro, Javier P. Gisbert, on behalf of the Young Group of GETECCU
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 19, p 4402 (2021)
Background: The impact of biologics on the risk of postoperative complications (PC) in inflammatory bowel disease (IBD) is still an ongoing debate. This lack of evidence is more relevant for ustekinumab and vedolizumab. Aims: To evaluate the impact o
Externí odkaz:
https://doaj.org/article/b8ec0ca77d6340f0b35b06cd75226f74
Autor:
Emilio José Laserna-Mendieta, Pilar Navarro, Sergio Casabona-Francés, Edoardo V Savarino, Isabel Pérez-Martínez, Danila Guagnozzi, Jesús Barrio, Antonia Perello, Antonio Guardiola-Arévalo, María Elena Betoré-Glaria, Leonardo Blas-Jhon, Francesca Racca, Anne Lund Krarup, Carolina Gutiérrez-Junquera, Sonia Fernández-Fernández, Susana De la Riva, Juan E Naves, Silvia Carrión, Natalia García-Morales, Valentín Roales, Juan Armando Rodríguez-Oballe, Raffaella Dainese, Alba Rodríguez-Sánchez, María Lluisa Masiques-Mas, Sara Feo-Ortega, Matteo Ghisa, Daria Maniero, Adolfo Suarez, Ronald Llerena-Castro, Paula Gil-Simón, Luisa de la Peña-Negro, Alicia Granja-Navacerrada, Javier Alcedo, Lonore Hurtado de Mendoza-Guena, Gaia Pellegatta, María Teresa Pérez-Fernández, Cecilio Santander, Sonsoles Tamarit-Sebastián, Ángel Arias, Alfredo J. Lucendo
Publikováno v:
Digestive and Liver Disease.
Autor:
Adrián Pintado, Isabel Pérez-Martínez, Isabel M. Aragón, José Antonio Gutiérrez-Barranquero, Antonio de Vicente, Francisco M. Cazorla, Cayo Ramos
Publikováno v:
Microorganisms, Vol 9, Iss 7, p 1388 (2021)
The rhizobacterium Pseudomonas alcaligenes AVO110 exhibits antagonism toward the phytopathogenic fungus Rosellinia necatrix. This strain efficiently colonizes R. necatrix hyphae and is able to feed on their exudates. Here, we report the complete geno
Externí odkaz:
https://doaj.org/article/b9be980c27854141a67e396a6ad015a4
Autor:
Jorge Federico Arturo Landa-Arreguin, Ruth Esther Villanueva-Estrada, Iván Morales-Arredondo, Salvatore Inguaggiato, Augusto Rodríguez-Díaz, Isabel Pérez-Martínez, Roberto Rocha-Miller, Rubén Bernard-Romero, Enrique Tello-Hinojosa
Publikováno v:
SSRN Electronic Journal.